The trial was paused after an “unexplained” illness in one of its participants and in compliance with regulatory standards, the company said.
Johnson & Johnson pauses clinical trials for a Covid vaccine over patient illness
More Stories
Brazil rolls out COVID-19 vaccination plan
First Pfizer COVID-19 vaccine shipments to be delivered to US distribution sites starting Monday
CDC advisory panel recommends Covid-19 vaccine for people 16 and over